The noradrenergic system in the prefrontal cortex (PFC) is involved in many physiological and psychological processes, including working memory and mood control. To understand the functions of the noradrenergic system, we examined the regulation of NMDA receptors (NMDARs), key players in cognition and emotion, by ␣1-and ␣2-adrenergic receptors (␣1-ARs, ␣2-ARs) in PFC pyramidal neurons. Applying norepinephrine or a norepinephrine transporter inhibitor reduced the amplitude but not paired-pulse ratio of NMDAR-mediated excitatory postsynaptic currents (EPSC) in PFC slices. Specific ␣1-AR or ␣2-AR agonists also decreased NMDAR-EPSC amplitude and whole-cell NMDAR current amplitude in dissociated PFC neurons. The ␣1-AR effect depended on the phospholipase C-inositol 1,4,5-trisphosphate-Ca 2؉ pathway, whereas the ␣2-AR effect depended on protein kinase A and the microtubule-based transport of NMDARs that is regulated by ERK signaling. Furthermore, two members of the RGS family, RGS2 and RGS4, were found to down-regulate the effect of ␣1-AR on NMDAR currents, whereas only RGS4 was involved in inhibiting ␣2-AR regulation of NMDAR currents. The regulating effects of RGS2/4 on ␣1-AR signaling were lost in mutant mice lacking spinophilin, which binds several RGS members and G protein-coupled receptors, whereas the effect of RGS4 on ␣2-AR signaling was not altered in spinophilin-knockout mice. Our work suggests that activation of ␣1-ARs or ␣2-ARs suppresses NMDAR currents in PFC neurons by distinct mechanisms. The effect of ␣1-ARs is modified by RGS2/4 that are recruited to the receptor complex by spinophilin, whereas the effect of ␣2-ARs is modified by RGS4 independent of spinophilin.A drenergic receptors (ARs) can be divided into three main types: ␣1 (␣ 1A-D ), ␣2 (␣ 2A-C ), and  (1-3), based on sequence information, receptor pharmacology, and signaling mechanisms. Although -ARs are located mainly in the cardiovascular system, most ␣1-and ␣2-AR subtypes (except ␣ 1C and ␣ 2B ) are highly expressed in CNS regions, e.g., prefrontal cortex (PFC), hippocampus, and brainstem. Norepinephrine, through the action of ␣1-ARs and ␣2-ARs, has been implicated in many key functions of PFC, including working memory and emotional control (1-3). An aberrant noradrenergic system, complementing altered serotonergic or dopaminergic signaling, contributes significantly to the pathophysiology of a variety of neuropsychiatric diseases associated with PFC dysfunction, such as depression, anxiety, schizophrenia, and attention-deficit hyperactivity disorder (4-7). Therefore, modifying noradrenergic signaling has been considered one of the key therapeutic actions of many antidepressants, anxiolytic drugs, and antipsychotics (8, 9). To understand the functional role of ␣1-and ␣2-ARs, we need to know their cellular targets that are important for cognition and emotion. The NMDAR channel has been implicated in normal cognitive processes and mental disorders (10-12), which makes it a potentially important target by which ␣1-and ␣2-ARs may regulate PFC ...